Alzheimer's disease (AD) is a progressive neurodegenerative disorder closely associated with oxidative stress, which plays a pivotal role in neuronal damage and disease progression. The Keap1-Nrf2-ARE signaling pathway plays a crucial role in regulating cellular responses to oxidative stress. Keap1 inhibits Nrf2 by maintaining its low expression, thus controlling antioxidant gene expression. Cistanche flavonoids, natural polyphenolic compounds, have been shown to activate this pathway. They suppress Keap1, preventing Nrf2 degradation and promoting its translocation to the nucleus, where it activates the antioxidant response element (ARE). This process significantly increases the production of antioxidant enzymes, such as superoxide dismutase and glutathione peroxidase. Elevated enzyme levels enhance cellular antioxidant defenses, reduce oxidative damage at the cellular and neuronal levels, and improve cognitive function in AD mouse models. The study examined the molecular composition of Cistanche flavonoids and their impact on the Keap1-Nrf2-ARE pathway, revealing their potential in mitigating AD-related changes. By neutralizing free radicals and enhancing antioxidant defenses, Cistanche flavonoids may offer a promising approach to counteract AD pathology. This comprehensive analysis underscores their therapeutic potential in alleviating AD through oxidative stress reduction and antioxidant activation.
BuccellatoFRD’AncaMFenoglioC, et al.Role of oxidative damage in Alzheimer’s disease and neurodegeneration: From pathogenic mechanisms to biomarker discovery. Antioxidants2021; 10: 1353.
2.
Mattace-RasoF. Is memantine + acetylcholinesterase inhibitor treatment superior to either therapy alone in Alzheimer’s disease?J Alzheimers Dis2014; 41: 641–642.
3.
MinochaTBirlaHObaidAA, et al.Flavonoids as promising neuroprotectants and their therapeutic potential against Alzheimer’s disease. Oxid Med Cell Longev2022; 2022: e6038996.
4.
LiuJHanXZhangT, et al.Reactive oxygen species (ROS) scavenging biomaterials for anti-inflammatory diseases: From mechanism to therapy. J Hematol Oncol2023; 16: 127.
5.
SpagnuoloCMocciaSRussoGL. Anti-inflammatory effects of flavonoids in neurodegenerative disorders. Eur J Med Chem2018; 153: 105–115.
6.
MelroseJ. The potential of flavonoids and flavonoid metabolites in the treatment of neurodegenerative pathology in disorders of cognitive decline. Antioxidants2023; 12: 663.
7.
ZhangSMaYChenJ, et al.Chemical composition, pharmacological effects, and parasitic mechanisms of Cistanche deserticola: An update. Phytomedicine2024; 132: 155808.
8.
QiLMaYZhengL, et al.Combined transcriptome and metabolome analysis highlights a central role of AmMYB30 in MeJA induced flavonoid accumulation in Astragalus membranaceus. Food Biosci2024; 61: 104565.
9.
CacabelosRTorrellasCCarreraI, et al.Novel therapeutic strategies for dementia. CNS Neurol Disord Drug Targets2016; 15: 141–241.
10.
WongKRiazMXieY, et al.Review of current strategies for delivering Alzheimer’s disease drugs across the blood-brain barrier. Int J Mol Sci2019; 20: 381.
11.
FarinaMVieiraLEButtariB, et al.The Nrf2 pathway in ischemic stroke: A review. Molecules2021; 26: 5001.
12.
WangLJiaJXZhangSB, et al.The protective effect and mechanism of glycosides of Cistanche deserticola on rats in middle cerebral artery occlusion (MCAO) model. J Toxicol Environ Health A2024; 87: 448–456.
13.
SinghBKKumarAAhmadI, et al.Oxidative stress in zinc-induced dopaminergic neurodegeneration: Implications of superoxide dismutase and heme oxygenase-1. Free Radic Res2011; 45: 1207–1222.
14.
WangYZhangLDuZ, et al.Chemical diversity and prediction of potential cultivation areas of Cistanche herbs. Sci Rep2019; 9: 19724.
15.
MorikawaTXieHPanY, et al.A review of biologically active natural products from a desert plant Cistanche tubulosa. Chem Pharm Bull (Tokyo)2019; 67: 675–689.
16.
QasemJR. Parasitic weeds of the Orobanchaceae family and their natural hosts in Jordan. Weed Biol Manag2009; 9: 112–122.
17.
AliaFChouikhADjahraAB, et al.Comparative study of some physicochemical and biological properties of effect host species variation on the relationship Saharan parasitic plant Cistanche violaceae (Desf.) Beck. Not Sci Biol2021; 13: 11054.
18.
ZhouLGWuJY. Development and application of medicinal plant tissue cultures for production of drugs and herbal medicinals in China. Nat Prod Rep2006; 23: 789–810.
19.
BiCGuoSHuS, et al.The microbiota–gut–brain axis and its modulation in the therapy of depression: Comparison of efficacy of conventional drugs and traditional Chinese medicine approaches. Pharmacol Res2022; 183: 106372.
20.
Al-SnafiAE. Bioactive metabolites and pharmacology of Cistanche tubulosa: A review. IOSR J Pharm2020; 10: 37–46.
21.
LiYQChenYFangJY, et al.Integrated network pharmacology and zebrafish model to investigate dual-effects components of Cistanche tubulosa for treating both osteoporosis and Alzheimer’s disease. J Ethnopharmacol2020; 254: 112764.
22.
XuQFanWYeSF, et al.Cistanche tubulosa protects dopaminergic neurons through regulation of apoptosis and glial cell-derived neurotrophic factor: In vivo and in vitro. Front Aging Neurosci2016; 8: 276.
23.
Gutiérrez-CuevasJLópez-CifuentesDSandoval-RodriguezA, et al.Medicinal plant extracts against cardiometabolic risk factors associated with obesity: Molecular mechanisms and therapeutic targets. Pharmaceuticals (Basel)2024; 17: 967.
24.
LuoJHLiJShenZC, et al.Advances in health-promoting effects of natural polysaccharides: Regulation on Nrf2 antioxidant pathway. Front Nutr2023; 10: 1149720.
25.
ParchetaMŚwisłockaROrzechowskaS, et al.Recent developments in effective antioxidants: The structure and antioxidant properties. Materials (Basel)2021; 14: 1984.
26.
UmarMRehmanYAmbreenS, et al.Innovative approaches to Alzheimer’s therapy: Harnessing the power of heterocycles, oxidative stress management, and nanomaterial drug delivery system. Ageing Res Rev2024; 97: 102298.
27.
SunXZhengYTianL, et al.Metabolome profiling and molecular docking analysis revealed the metabolic differences and potential pharmacological mechanisms of the inflorescence and succulent stem of Cistanche deserticola. RSC Adv2021; 11: 27226–27245.
28.
ChenYPengFXingZ, et al.Beneficial effects of natural flavonoids on neuroinflammation. Front Immunol2022; 13: 1006434.
29.
WangCYeHZhengY, et al.Phenylethanoid glycosides of Cistanche improve learning and memory disorders in APP/PS1 mice by regulating glial cell activation and inhibiting TLR4/NF-κB signaling pathway. Neuromolecular Med2022; 25: 75–93.
30.
MaherP. The potential of flavonoids for the treatment of neurodegenerative diseases. Int J Mol Sci2019; 20: 3056.
31.
NumakawaTOdakaH. Brain-derived neurotrophic factor signaling in the pathophysiology of Alzheimer’s disease: Beneficial effects of flavonoids for neuroprotection. Int J Mol Sci2021; 22: 5719.
32.
WangTZhangXXieW. Cistanche deserticola YC Ma, “desert ginseng”: A review. Am J Chin Med2012; 40: 1123–1141.
33.
AyazMSadiqAJunaidM, et al.Flavonoids as prospective neuroprotectants and their therapeutic propensity in aging-associated neurological disorders. Front Aging Neurosci2019; 11: 155.
34.
PengXChengKWMaJ, et al.Cinnamon bark proanthocyanidins as reactive carbonyl scavengers to prevent the formation of advanced glycation endproducts. J Agric Food Chem2008; 56: 1907–1911.
35.
YinYXuJIlyasI, et al.Bioactive flavonoids in protecting against endothelial dysfunction and atherosclerosis. Handb Exp Pharmacol2025; 287: 1–31.
36.
GaoYLiBLiuH, et al.Cistanche deserticola polysaccharides alleviate cognitive decline in aging model mice by restoring the gut microbiota-brain axis. Aging (Albany NY)2021; 13: 15320–15335.
37.
SuzukiTYamamotoM. Stress-sensing mechanisms and the physiological roles of the Keap1–Nrf2 system during cellular stress. J Biol Chem2017; 292: 16817–16824.
38.
TuWWangHLiS, et al.The anti-inflammatory and antioxidant mechanisms of the Keap1/Nrf2/ARE signaling pathway in chronic diseases. Aging Dis2019; 10: 637–651.
39.
BairdLYamamotoM. The Keap1–Nrf2 pathway: From mechanism to medical applications. In: SiesH (ed.) Oxidative stress. Cambridge: Academic Press, 2020, pp.125–147.
40.
AtiaAAbdullahA. Review of NRF2-regulated genes induced in response to antioxidants. Int J Med Res Health Sci2014; 3: 428–435.
41.
LuMCJiJAJiangZY, et al.The Keap1–Nrf2–ARE pathway as a potential preventive and therapeutic target: An update. Med Res Rev2016; 36: 924–963.
42.
KanwuguONGlukharevaTV. Activation of Nrf2 pathway as a protective mechanism against oxidative stress-induced diseases: Potential of astaxanthin. Arch Biochem Biophys2023; 741: 109601.
43.
Dayalan NaiduSDinkova-KostovaAT. KEAP1, a cysteine-based sensor and a drug target for the prevention and treatment of chronic disease. Open Biol2020; 10: 200105.
44.
LiWYuSLiuT, et al.Heterodimerization with small Maf proteins enhances nuclear retention of Nrf2 via masking the NESzip motif. Biochim Biophys Acta Mol Cell Res2008; 1783: 1847–1856.
45.
TianWRojo de la VegaMSchmidlinCJ, et al.Kelch-like ECH-Associated Protein 1 (KEAP1) differentially regulates nuclear factor erythroid-2–related factors 1 and 2 (NRF1 and NRF2). J Biol Chem2018; 293: 2029–2040.
46.
CuadradoA. Structural and functional characterization of Nrf2 degradation by glycogen synthase kinase 3/β-TrCP. Free Radic Biol Med2015; 88: 147–157.
47.
RaghunathASundarrajKNagarajanR, et al.Antioxidant response elements: Discovery, classes, regulation and potential applications. Redox Biol2018; 17: 297–314.
48.
ItohKMimuraJYamamotoM. Discovery of the negative regulator of Nrf2, Keap1: A historical overview. Antioxid Redox Signal2010; 13: 1665–1678.
49.
VilleneuveNFLauAZhangDD. Regulation of the Nrf2–Keap1 antioxidant response by the ubiquitin proteasome system: An insight into cullin-ring ubiquitin ligases. Antioxid Redox Signal2010; 13: 1699–1712.
50.
SaitoRSuzukiTHiramotoK, et al.Characterizations of three major cysteine sensors of Keap1 in stress response. Mol Cell Biol2016; 36: 271–284.
51.
HirotsuYKatsuokaFFunayamaR, et al.Nrf2–MafG heterodimers contribute globally to antioxidant and metabolic networks. Nucleic Acids Res2012; 40: 10228–10239.
52.
TavleevaMMBelykhESRybakAV, et al.Effects of antioxidant gene overexpression on stress resistance and malignization in vitro and in vivo: A review. Antioxidants (Basel)2022; 11: 2316.
53.
BabaMZGomathySWahediU. Role of Nrf2 pathway activation in neurological disorder: A brief review. J Pharmacol Pharmacother2022; 13: 229–238.
54.
SkibinskiGHwangVAndoDM, et al.Nrf2 mitigates LRRK2- and α-synuclein–induced neurodegeneration by modulating proteostasis. Proc Natl Acad Sci U S A2017; 114: 1165–1170.
55.
MuneerPMA. Nrf2 as a potential therapeutic target for traumatic brain injury. J Integr Neurosci2023; 22: 81.
56.
LauAVilleneuveNFSunZ, et al.Dual roles of Nrf2 in cancer. Pharmacol Res2008; 58: 262–270.
57.
BookheimerSYRennerBAEkstromA, et al.Pomegranate juice augments memory and fMRI activity in middle-aged and older adults with mild memory complaints. Evid Based Complement Alternat Med2013; 2013: 946298.
58.
EiseleYS. From soluble Aβ to progressive Aβ aggregation: Could prion-like templated misfolding play a role?Brain Pathol2013; 23: 333–341.
59.
WangQDongXZhangR, et al.Flavonoids with potential anti-amyloidogenic effects as therapeutic drugs for treating Alzheimer’s disease. J Alzheimers Dis2021; 84: 505–533.
60.
Medrano-JiménezEMeza-SosaKFUrbán-AragónJA, et al.Microglial activation in Alzheimer’s disease: The role of flavonoids and microRNAs. J Leukoc Biol2022; 112: 47–77.
61.
DodsonMShakyaAAnandhanA, et al.NRF2 and diabetes: The good, the bad, and the complex. Diabetes2022; 71: 2463–2476.
62.
FangJLuJHolmgrenA. Thioredoxin reductase is irreversibly modified by curcumin. J Biol Chem2005; 280: 25284–25290.
63.
HanGZhenWDaiY, et al.Dihuang-Yinzi alleviates cognition deficits via targeting energy-related metabolism in an Alzheimer mouse model as demonstrated by integration of metabolomics and network pharmacology. Front Aging Neurosci2022; 14: 857956.
64.
BaidyaRSarkarB. A systematic review of the traditional uses, chemistry, and curative aptitude of echinacoside—a phenylethanoid glycoside. Naunyn Schmiedebergs Arch Pharmacol2024; 397: 2071–2106.
65.
YaoSQXuZPGuoWX, et al.Neuroprotective effect of Cistanche deserticola glycosides in MPTP-induced Parkinson’s disease mouse model involves Nrf2 activation. J Toxicol Environ Health A2025; 88: 576–588.
66.
JiaXWangSZhouL, et al.Echinacoside protects against H2O2-induced oxidative damage in PC12 cells through the Nrf2/ARE pathway. Biosci Rep2019; 39: BSR20190579.
67.
ZhangYWuYZhangM, et al.Acteoside protects neurons against mitochondrial toxicity via activation of Nrf2 pathway leading to inhibition of oxidative stress and mitochondrial dysfunction. Int J Mol Sci2018; 19: 1746.
68.
KempurajDThangavelRKempurajDD, et al.Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma. Biofactors2021; 47: 190–197.
69.
LiFZhangLZhangX, et al.Rutin alleviates Pb-induced oxidative stress, inflammation and cell death via activating Nrf2/ARE system in SH-SY5Y cells. Neurotoxicology2024; 104: 1–10.
70.
XueTZhengDWenL, et al.Advance in Cistanche deserticola YC Ma polysaccharides: Isolation, structural characterization, bioactivities and application: A review. Int J Biol Macromol2024; 263: 134786.
71.
HuYHuangJLiY, et al.Cistanche deserticola polysaccharide induces melanogenesis in melanocytes and reduces oxidative stress via activating NRF2/HO-1 pathway. J Cell Mol Med2020; 24: 4023–4035.
72.
TakayaKAsouTKishiK. Cistanche deserticola polysaccharide reduces inflammation and aging phenotypes in dermal fibroblasts through activation of the NRF2/HO-1 pathway. Int J Mol Sci2023; 24: 15704.
